Alternatives for Treating Emergent Cardiogenic Shock
Impella 5.0® Via Transcaval Access Transcaval access can help meet the urgent clinical need for...
Managing Cardiogenic Shock
A Contemporary Survey of Cardiogenic Shock Management Practices Emmanouil Brilakis,...
ECMELLA/ECpella versus ECMO
LV Unloading Associated with Lower Mortality in Cardiogenic Shock Benedikt Schrage, MD is one of the...
Role of the PA Catheter in Managing Cardiogenic Shock
Complete Hemodynamic Profiling Associated with Lower In-Hospital Mortality What is the role of the PA catheter...
Closing Summation, RECOVER III, and Intro to RECOVER IV
Presented by William O'Neill, MD William O’Neill, MD, reviews RECOVER III data showi...
Importance of Timing and Impact of Extensive Revascularization on Long-Term Survival in Cardiogenic Shock: Insights From European Multi-Center Studies
Presented by Giuseppe Tarantini, MD, PhD Giuseppe Tarantini, MD, PhD, FESC discusses insights from...
Efficacy and Safety of ALL Impella Use in Japanese Patients With Drug-Resistant Acute HF: Insight From Japan J-PVAD Study
Presented by Junya Ako, MD Junya Ako, MD, presents the interim analysis of data from 819 patients fro...
Achieving >70% AMI-CS Survival: Insight From National Cardiogenic Shock Initiative
Presented by William O'Neill, MD William O’Neill, MD, discusses insights from the National Ca...
Panoulas Paper on Impella Experience in the UK
Impella® Support: Clinical Utility, Indications, and Outcomes Vasileios Panoulas, MD, PhD, MRCP, FESC...
Optimal Target MAP in Post-Cardiac Arrest AMI Shock
MAP between 80 and 100 mmHg Reduces Myocardial Injury Do blood pressure targets in the 36 hours after...
Schäfer Paper on Impella® Heart Pump Use in AMI Cardiogenic Shock
Influence of Impella Treatment Timing and Predicted Risk on Mortality Prof. Andreas Schäfer, MD discu...
Keller Paper on LV Unloading in ECMO
Better Than Anticipated Survival with Impella CP® and ECMO in Cardiogenic Shock Steven P. Keller, MD,...
Lemor Paper Comparing Impella to ECMO in AMICS
Impella vs ECMO: Clinical Outcomes, Complications, Length of Stay, and Cost Dr. Alejandro Lemor discu...
Hanson Paper on Survival in AMICS
SCAI Shock Classification Helps Predict Survival Ivan Hanson, MD discusses his recently published pap...
Ramzy Paper: First Published Clinical Experience on Impella 5.5 with SmartAssist for Cardiogenic Shock
Impressive Survival and Heart Recovery Rates with Impella 5.5 Danny Ramzy, MD discusses his experienc...
Pappalardo Paper on Bedside Impella® Insertion
ICU Impella Insertion with TEE Guidance in Cardiogenic Shock Federico Pappalardo, MD discusses his re...
Mechanical Circulatory Support in AMI Cardiogenic Shock
Insights on MCS Use and Timing from Dr. Jacob Møller in Denmark Jacob Møller MD, PhD, an intensivist...
Revascularization Strategies for Multivessel CAD
Retrospective Analysis from NCSI of Multivessel Intervention With Impella for AMI Shock Dr. Bill O’Neill...
National Trends on the Incidence and Clinical Outcomes of Stroke
How common is it to see stroke in a patient with cardiogenic shock? Navin Kapur, MD, FAHA, FACC, FSCAI, is the executi...
Managing Acute MI Cardiogenic Shock
Developing Best Practices with Dr. Bill O’Neill “What are the foundations for developing best practices in managing ac...
National Cardiogenic Shock Initiative Update
Dr. Bill O’Neill Discusses Ongoing Progress in NCSI Bill O’Neill, MD presents some of the overall out...
Top Cardiogenic Shock Treatment Objectives and Device Options
What is Cardiogenic Shock? Cardiogenic shock is a life-threatening condition that occurs when the heart can no longer...
NCSI Findings Regarding Right Ventricular Dysfunction
About 40% of AMICS Patients Develop Right Ventricular Dysfunction Dr. Babar Basir, an interventionalist at Henry Ford...
Multicenter Impella Experience Data from Dr. Andreas Schäfer
Impella for AMI Cardiogenic Shock Dr. Andreas Schäfer, an interventional cardiologist and intensivist from Hannover, G...
Duane Pinto Comments on SCAI Vascular Access and Closure Best Practices
A Practical Resource for Practicing Physicians Duane Pinto, MD, MPH, one of the nation’s experts on v...
Where’s the Cardiogenic Shock Treatment Data?
Looking to Real-world Evidence in Cardiogenic Shock Dr. William O’Neill discusses...
Clinical Paper: Beyond Reperfusion by Jerry Curran
Acute Ventricular Unloading and Cardioprotection During MI Jerry Curran PhD, Senior Scientist at Abio...
Impella Support Pre-PCI for AMICS is Associated with Higher Survival in Women
Reference: J Interven Cardiol 2016; 29:248–256. Card...
INOVA Heart and Vascular Heart Recovery Initiative
Instituting a Cardiogenic Shock Protocol to Improve Outcomes Alexander Truesdell, MD and Behnam Tehrani, MD, intervent...
Dr. Bill O’Neill: New Data from NCSI & Improving Outcomes in Cardiogenic Shock
“This is a coalition of the willing…I think all of you have to decide tomorrow when you go home, in your hospital h...
Improving Survival in Cardiogenic Shock by Adopting a Uniform Approach to Systems of Care
Reference: J Am Coll Cardiol 2...
The Door-to-Unloading (DTU) STEMI Safety & Feasibility Trial
Navin Kapur, MD, executive director of the CardioVascular Center for Research and Innovation at Tufts Medical Center, discusses...
National Cardiogenic Shock Initiative: 1 Year Later
Video Chapters:The Impact of The Cardiogenic Shock Initiative (NCSI):...
Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device
Dr. William O’Neill outlines his recent publication of 15,529 AMI cardiogenic shock patients from the Impella Quality (IQ) data...
